Loading...
Derniers dépôts
-
Loig Vaugier, Elvire Martin-Mervoyer, Loic Ah-Thiane, Martin Langé, Luc Ollivier, et al.. How to contour the different heart subregions for future deep-learning modeling of the heart: A practical pictorial proposal for radiation oncologists. Clinical and Translational Radiation Oncology, 2024, 45, pp.100718. ⟨10.1016/j.ctro.2023.100718⟩. ⟨hal-04791592⟩
-
Julien Leenhardt, Luc Choisnard, Maelle Plasse, Valérie Ardisson, Nicolas de Leiris, et al.. Bacterial survival in radiopharmaceutical solutions: a critical impact on current practices. European Association of Nuclear Medicine, issuing body - EJNMMI radiopharmacy and chemistry, 2023, 8 (1), pp.34. ⟨10.1186/s41181-023-00221-3⟩. ⟨hal-04777250⟩
-
Jesus M Eraso, Randall J Olsen, S Wesley Long, Ryan Gadd, Sarrah Boukthir, et al.. Integrative genomic, virulence, and transcriptomic analysis of emergent Streptococcus dysgalactiae subspecies equisimilis (SDSE) emm type stG62647 isolates causing human infections. mBio, 2024, pp.e0257824. ⟨10.1128/mbio.02578-24⟩. ⟨hal-04765930⟩
-
Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, et al.. Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. Nature Medicine, 2023, 29 (10), pp.2665-2665. ⟨10.1038/s41591-023-02624-w⟩. ⟨hal-04755672⟩
-
Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, et al.. Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. Nature Medicine, 2024, 30 (7), pp.2089 - 2089. ⟨10.1038/s41591-024-03053-z⟩. ⟨hal-04753011⟩
-
Marie-Pierre Bonnet, Perrine Guckert, Cécile Boccara, Chafia Daoui, Hélène Beloeil. New set of indicators with consensus definition for anaesthesia-related severe morbidity: A scoping review followed by a Delphi study. Journal of Clinical Anesthesia, 2024, 99, pp.111626. ⟨10.1016/j.jclinane.2024.111626⟩. ⟨hal-04719981v2⟩
-
Clémence Pierre, Yannick Le Guen, Caroline Giordanengo, Thomas Goter, Hervé Léna, et al.. Safety and efficacy of immunotherapy using a double-dose regimen in advanced non-small cell lung cancer (NSCLC): results of IDEE study. Translational Lung Cancer Research, 2024, 13 (8), pp.1807-1815. ⟨10.21037/tlcr-24-141⟩. ⟨hal-04719854v2⟩
-
Marcela Carausu, Matthieu Carton, Luc Cabel, Anne Patsouris, Christelle Levy, et al.. Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database. Therapeutic Advances in Medical Oncology, 2022, 14, pp.175883592210770. ⟨10.1177/17588359221077082⟩. ⟨hal-03867853⟩
-
Vincent Hautefeuille, Nicolas Williet, Anthony Turpin, Bertrand Napoleon, Aurélien Dupré, et al.. Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR). Digestive and Liver Disease, 2024, 56 (9), pp.1452-1460. ⟨10.1016/j.dld.2024.04.027⟩. ⟨hal-04603000⟩
-
Margaux Mekkan-Bouv Hez, Lea Derbey, Louis de Mestier, Lorenzo D, Thomas Walter, et al.. Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study. International Journal of Surgery, 2024, ⟨10.1097/js9.0000000000001382⟩. ⟨hal-04575949⟩